These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34531080)

  • 21. Challenges in measuring supplemental immunization activity coverage among measles zero-dose children.
    Cutts FT; Danovaro-Holliday MC; Rhoda DA
    Vaccine; 2021 Mar; 39(9):1359-1363. PubMed ID: 33551302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Value Health; 2020 Jul; 23(7):891-897. PubMed ID: 32762991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Planning for supplemental immunization activities using the readiness assessment dashboard: Experience from 2017/2018 Measles vaccination campaign, Nigeria.
    Terna Richard M; Taiwo L; Jean Baptiste AE; Bawa S; Dieng B; Wiwa O; Lambo K; Braka F; Shuaib F; Oteri J
    Vaccine; 2021 Nov; 39 Suppl 3():C21-C28. PubMed ID: 34247903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supplementary immunization activities to achieve measles elimination: experience of the European Region.
    Khetsuriani N; Deshevoi S; Goel A; Spika J; Martin R; Emiroglu N
    J Infect Dis; 2011 Jul; 204 Suppl 1():S343-52. PubMed ID: 21666183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From the Centers for Disease Control and Prevention. Measles incidence before and after supplementary vaccination activities--Lusaka, Zambia, 1996-2000.
    JAMA; 2001 Jul; 286(4):411-3. PubMed ID: 11484730
    [No Abstract]   [Full Text] [Related]  

  • 26. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
    Oteri J; Idi Hussaini M; Bawa S; Ibizugbe S; Lambo K; Mogekwu F; Wiwa O; Seaman V; Kolbe-Booysen O; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C29-C37. PubMed ID: 33478790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of declining vaccination coverage on measles control: a case study of Abia state Nigeria.
    Umeh CA; Ahaneku HP
    Pan Afr Med J; 2013; 15():105. PubMed ID: 24244791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles Virus Infection Among Vaccinated and Unvaccinated Children in Nigeria.
    Faneye AO; Adeniji JA; Olusola BA; Motayo BO; Akintunde GB
    Viral Immunol; 2015; 28(6):304-8. PubMed ID: 26102341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: A case study of 2017/18 measles campaign in Borno state, Nigeria.
    Babakura B; Nomhwange T; Jean Baptiste AE; Dede O; Taiwo L; Abba S; Soyemi M; Idowu AM; Terna Richard M; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C66-C75. PubMed ID: 33546886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ; Orenstein WA
    Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.
    Wagai JN; Rhoda D; Prier M; Trimmer MK; Clary CB; Oteri J; Okposen B; Adeniran A; Danovaro-Holliday C; Cutts F
    PLoS One; 2021; 16(2):e0247415. PubMed ID: 33635913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A; Vincent A; Selvaraj K; Manikandan M
    Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA; François J; Wannemuehler K; Magloire R; Danovaro-Holliday MC; Flannery B; Cavallaro KF; Fitter DL; Purcell N; Dismer A; Tappero JW; Vertefeuille JF; Hyde TB
    Trop Med Int Health; 2014 Sep; 19(9):1105-15. PubMed ID: 25041586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in measles mortality reduction in Ethiopia, 2002-2009.
    Mitiku K; Bedada T; Masresha BG; Kegne W; Nafo-Traoré F; Tesfaye N; Yigzaw A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S232-8. PubMed ID: 21666166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress toward measles elimination in the People's Republic of China, 2000-2009.
    Ma C; An Z; Hao L; Cairns KL; Zhang Y; Ma J; Cao L; Wen N; Xu W; Liang X; Yang W; Luo H
    J Infect Dis; 2011 Jul; 204 Suppl 1():S447-54. PubMed ID: 21666198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles vaccine potency and sero-conversion rates among infants receiving measles immunization in Ilorin, Kwara State, Nigeria.
    Fowotade A; Okonko IO; Nwabuisi C; Bakare RA; Fadeyi A; Adu FD
    J Immunoassay Immunochem; 2015; 36(2):195-209. PubMed ID: 24825255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated measles control--Cambodia, 1999-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jan; 52(1):4-6. PubMed ID: 12549899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya.
    Mburu CN; Ojal J; Chebet R; Akech D; Karia B; Tuju J; Sigilai A; Abbas K; Jit M; Funk S; Smits G; van Gageldonk PGM; van der Klis FRM; Tabu C; Nokes DJ; ; Scott J; Flasche S; Adetifa I
    BMC Med; 2021 Feb; 19(1):35. PubMed ID: 33531015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An assessment of the effectiveness of the measles immunization programme in Lagos, Nigeria.
    Ogunmekan DA; Bracken P; Marshall WC
    Ann Trop Med Parasitol; 1981 Feb; 75(1):87-92. PubMed ID: 7271359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.